ArticleNature catalysis2022
Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme.
John Blazeck et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it